Finerenone is a new type of medicine used to treat kidney and heart problems, especially in people with chronic kidney disease (CKD) linked to type 2 diabetes. It is a non-steroidal mineralocorticoid receptor blocker (MRA), which is a type of drug. While older medicines in this group, such as spironolactone and eplerenone, have been used for years, finerenone works in a more selective way and may cause fewer side effects.
The main approved use of finerenone is for people who have:
Chronic Kidney Disease (CKD) with Type 2 Diabetes: This disease predisposes the body to kidney failure and heart complications. Finerenone is used to stop kidney problems from getting more severe and lower the risk of having to go to the hospital for heart failure.
Heart protection: As kidney disease and diabetes strain the heart, finerenone also reduces cardiovascular events like heart attacks, stroke, or heart failure.
Doctors usually prescribe finerenone in addition to other standard medicines for diabetes, high blood pressure, or kidney protection. For example, it may be used along with ACE inhibitors or angiotensin receptor blockers.
To learn more about finerenone, it is better to know little information about the hormone system of the body - The renin-angiotensin-aldosterone system (RAAS) regulates blood pressure and the balance of fluids. Aldosterone is a hormone in this system. It binds to mineralocorticoid receptors in the heart, kidneys, and blood vessels. In the case of excessive binding, aldosterone has pernicious effects: retention of sodium and water, raised blood pressure, tissue scarring, and inflammation. Finerenone functions by inhibiting such receptors of mineralocortisoids. Finerenone is non-steroidal and very selective. This implies that it inhibits the negative action of aldosterone, yet has little effect on other hormone systems.
Because finerenone affects hormones and kidney function, it can interact with several other medicines. Some important interactions include:
Potassium-Raising Drugs: Because finerenone lowers the effects of aldosterone, it can raise potassium levels in the blood. It should not be used in combination with potassium supplements, salt substitutes with potassium or other potassium-sparing medications.
ACE inhibitors and ARBs: These drugs are often used with finerenone, but since they also raise potassium levels, doctors must monitor blood potassium closely.
Strong CYP3A4 inhibitors and Inducers: As CYP3A4 operates within the liver, it breaks down finerenone. Medicines that block CYP3A4 can raise the amount of finerenone in the body, which can cause more side effects. Medicines that speed up CYP3A4 can reduce its effect, making the drug less useful.
Other Blood Pressure Medicines: Finerenone may enhance the blood pressure–lowering effect of some drugs, so doctors may adjust doses to prevent dizziness or fainting.
High potassium is the most significant side effect to monitor and it may be serious in case of no treatment. Doctors often check the amount of potassium and kidney function before starting finerenone treatment and while it's being used. Low blood pressure, slight dizziness, and trouble with how the kidneys work are some other possible side effects. Finerenone is however normally better tolerated compared to older MRAs.
Finerenone is a modern medicine that offers kidney and heart protection in people with chronic kidney disease linked to type 2 diabetes. By blocking mineralocorticoid receptors in a selective, non-steroidal way, it reduces inflammation, scarring, and strain on the heart.
Nonetheless, it should be applied cautiously, particularly when drugs that affect potassium or liver enzyme CYP3A4 are used. Frequent checks of blood tests are necessary. Finerenone is a promising alternative that can improve long-term outcomes without causing as many side effects as older medicines in its category, so this drug is beneficial to patients in danger of kidney failure or heart disease.
Other Recommended Products: Dapoxetine: Uses, Interactions, Mechanism Of Action